Literature DB >> 25052342

Impaired decision-making and selective cortical frontal thinning in Cushing's syndrome.

Iris Crespo1, Granell-Moreno Esther, Alicia Santos, Elena Valassi, Vives-Gilabert Yolanda, Manel De Juan-Delago, Susan M Webb, Beatriz Gómez-Ansón, Eugenia Resmini.   

Abstract

CONTEXT AND
OBJECTIVE: Cushing's syndrome (CS) is caused by a glucocorticoid excess. This hypercortisolism can damage the prefrontal cortex, known to be important in decision-making. Our aim was to evaluate decision-making in CS and to explore cortical thickness. SUBJECTS AND METHODS: Thirty-five patients with CS (27 cured, eight medically treated) and thirty-five matched controls were evaluated using Iowa gambling task (IGT) and 3 Tesla magnetic resonance imaging (MRI) to assess cortical thickness. The IGT evaluates decision-making, including strategy and learning during the test. Cortical thickness was determined on MRI using freesurfer software tools, including a whole-brain analysis.
RESULTS: There were no differences between medically treated and cured CS patients. They presented an altered decision-making strategy compared to controls, choosing a lower number of the safer cards (P < 0·05). They showed more difficulties than controls to learn the correct profiles of wins and losses for each card group (P < 0·05). In whole-brain analysis, patients with CS showed decreased cortical thickness in the left superior frontal cortex, left precentral cortex, left insular cortex, left and right rostral anterior cingulate cortex, and right caudal middle frontal cortex compared to controls (P < 0·001).
CONCLUSIONS: Patients with CS failed to learn advantageous strategies and their behaviour was driven by short-term reward and long-term punishment, indicating learning problems because they did not use previous experience as a feedback factor to regulate their choices. These alterations in decision-making and the decreased cortical thickness in frontal areas suggest that chronic hypercortisolism promotes brain changes which are not completely reversible after endocrine remission.
© 2014 John Wiley & Sons Ltd.

Entities:  

Mesh:

Year:  2014        PMID: 25052342     DOI: 10.1111/cen.12564

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  11 in total

1.  Brain metabolite abnormalities in ventromedial prefrontal cortex are related to duration of hypercortisolism and anxiety in patients with Cushing's syndrome.

Authors:  Iris Crespo; Alicia Santos; Beatriz Gómez-Ansón; Olga López-Mourelo; Patricia Pires; Yolanda Vives-Gilabert; Susan M Webb; Eugenia Resmini
Journal:  Endocrine       Date:  2016-04-21       Impact factor: 3.633

Review 2.  Dynamic changes of views on the brain changes of Cushing's syndrome using different computer-assisted tool.

Authors:  Lu Gao; Lu Liu; Lin Shi; Yishan Luo; Zihao Wang; Xiaopeng Guo; Bing Xing
Journal:  Rev Endocr Metab Disord       Date:  2020-03       Impact factor: 6.514

3.  Prolonged corticosterone exposure induces dendritic spine remodeling and attrition in the rat medial prefrontal cortex.

Authors:  Rachel M Anderson; Ryan M Glanz; Shane B Johnson; Mary M Miller; Sara A Romig-Martin; Jason J Radley
Journal:  J Comp Neurol       Date:  2016-05-17       Impact factor: 3.215

4.  Neuropsychiatric and cardiometabolic comorbidities in patients with previously diagnosed Cushing's disease: a longitudinal observational study.

Authors:  C Dimopoulou; V Geraedts; G K Stalla; C Sievers
Journal:  BMJ Open       Date:  2015-03-27       Impact factor: 2.692

5.  Glucocorticoid Regulation of Food-Choice Behavior in Humans: Evidence from Cushing's Syndrome.

Authors:  Scott J Moeller; Lizette Couto; Vanessa Cohen; Yelena Lalazar; Iouri Makotkine; Nia Williams; Rachel Yehuda; Rita Z Goldstein; Eliza B Geer
Journal:  Front Neurosci       Date:  2016-02-05       Impact factor: 4.677

6.  Microstructural white matter alterations and hippocampal volumes are associated with cognitive deficits in craniopharyngioma.

Authors:  S Fjalldal; C Follin; D Svärd; L Rylander; S Gabery; Å Petersén; D van Westen; P C Sundgren; I M Björkman-Burtscher; J Lätt; B Ekman; A Johanson; E M Erfurth
Journal:  Eur J Endocrinol       Date:  2018-03-29       Impact factor: 6.664

Review 7.  Quality of Life in Patients With Cushing's Disease.

Authors:  Alicia Santos; Eugenia Resmini; Mª Antonia Martínez Momblán; Elena Valassi; Luciana Martel; Susan M Webb
Journal:  Front Endocrinol (Lausanne)       Date:  2019-12-11       Impact factor: 5.555

8.  Effects of Long-Term Endogenous Corticosteroid Exposure on Brain Volume and Glial Cells in the AdKO Mouse.

Authors:  Jorge Miguel Amaya; Ernst Suidgeest; Isabelle Sahut-Barnola; Typhanie Dumontet; Nathanaëlle Montanier; Guilhem Pagès; Cécile Keller; Louise van der Weerd; Alberto M Pereira; Antoine Martinez; Onno C Meijer
Journal:  Front Neurosci       Date:  2021-02-10       Impact factor: 4.677

9.  Moral judgment and hormones: A systematic literature review.

Authors:  Carolina Coelho Moniz de Campos Freitas; Flávia de Lima Osório
Journal:  PLoS One       Date:  2022-04-06       Impact factor: 3.240

10.  Gene expression changes in the brain of a Cushing's syndrome mouse model.

Authors:  Jorge Miguel Amaya; Eva M G Viho; Hetty C M Sips; Reshma A Lalai; Isabelle Sahut-Barnola; Typhanie Dumontet; Nathanaëlle Montanier; Alberto M Pereira; Antoine Martinez; Onno C Meijer
Journal:  J Neuroendocrinol       Date:  2022-04-01       Impact factor: 3.870

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.